Hyperhomocysteinemia as a risk factor for cardiovascular disease in patients undergoing hemodialysis

J A Friedman1, J T Dwyer

  • 1New England Medical Center, Boston, MA, USA.

Nutrition Reviews
|July 1, 1995
PubMed

Insights

High homocysteine levels are common in kidney disease patients and may increase cardiovascular risk. Folic acid can lower, but not eliminate, these levels, with ongoing research into its impact on heart health.

Area of Science:

  • Nephrology
  • Cardiology
  • Nutritional Science

Background:

  • Hyperhomocysteinemia is prevalent in end-stage renal disease (ESRD) and dialysis patients.
  • Elevated homocysteine is a potential risk factor for cardiovascular disease (CVD) in this population.

Purpose of the Study:

  • To investigate the role of hyperhomocysteinemia in cardiovascular risk among renal disease patients.
  • To evaluate the efficacy of folic acid supplementation in managing hyperhomocysteinemia in dialysis patients.

Main Methods:

  • Observational analysis of homocysteine levels in ESRD and dialysis patients.
  • Assessment of folic acid's impact on homocysteine concentrations.

Main Results:

  • Hyperhomocysteinemia is confirmed in patients with end-stage renal disease and those on dialysis.
  • Folic acid supplementation demonstrates a capacity to reduce, though not fully normalize, homocysteine levels.

Conclusions:

  • Hyperhomocysteinemia is a significant finding in renal disease patients, potentially contributing to CVD.
  • Folic acid offers partial correction of hyperhomocysteinemia, but further evidence is needed to confirm its cardiovascular benefits.

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
826
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.7K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.5K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
575
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
324
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.4K